Multiple Myeloma (MM) is a B-cell malignancy that is characterized by osteolytic bone lesions. It has been postulated that positive feedback loops in the interactions between MM cells and the bone microenvironment form reinforcing 'vicious cycles', resulting in more bone resorption and MM cell population growth in the bone microenvironment. Despite many identified MM-bone interactions, the combined effect of these interactions and their relative importance are unknown. In this paper, we develop a computational model of MM-bone interactions and clarify whether the intercellular signaling mechanisms implemented in this model appropriately drive MM disease progression. This new computational model is based on the previous bone remodeling model...
Multiple myeloma (MM) is a B cell malignancy resulting in osteolytic lesions and fractures. In the d...
Bone destruction is the hallmark of multiple myeloma (MM) due to the high capacity of malignant plas...
Multiple myeloma (MM) is a plasma cell malignancy characterized by the high capacity to induce bone ...
Multiple Myeloma (MM) is a B-cell malignancy that is characterized by osteolytic bone lesions. It ha...
Multiple myeloma (MM) is the second most common haematological malignancy and results in destructive...
BACKGROUND: Multiple myeloma is a hematologic malignancy associated with the development of a destru...
© 2011 Dr. Yan WangMultiple Myeloma (MM) - Bone interactions are critical to systematic understandin...
Multiple myeloma (MM) is a hematologic malignancy of differentiated plasma cells that accumulates an...
Multiple myeloma (MM) is a hematologic malignancy of differentiated plasma cells that accumulates an...
The standard model of multiple myeloma (MM) oncogenesis is based on the genetic instability of MM ce...
International audienceMultiple myeloma (MM) is a genetically complex hematological cancer that is ch...
Cancer cells and stromal cells cooperate by exchanging diffusible factors that sustain tumor growth,...
International audienceThe standard model of multiple myeloma (MM) relies on genetic instability in t...
Multiple myeloma (MM) is a hematologic malignancy of plasma cells proliferating in the bone marrow a...
Multiple myeloma is a malignant bone marrow plasma cell tumor which is responsible for approximately...
Multiple myeloma (MM) is a B cell malignancy resulting in osteolytic lesions and fractures. In the d...
Bone destruction is the hallmark of multiple myeloma (MM) due to the high capacity of malignant plas...
Multiple myeloma (MM) is a plasma cell malignancy characterized by the high capacity to induce bone ...
Multiple Myeloma (MM) is a B-cell malignancy that is characterized by osteolytic bone lesions. It ha...
Multiple myeloma (MM) is the second most common haematological malignancy and results in destructive...
BACKGROUND: Multiple myeloma is a hematologic malignancy associated with the development of a destru...
© 2011 Dr. Yan WangMultiple Myeloma (MM) - Bone interactions are critical to systematic understandin...
Multiple myeloma (MM) is a hematologic malignancy of differentiated plasma cells that accumulates an...
Multiple myeloma (MM) is a hematologic malignancy of differentiated plasma cells that accumulates an...
The standard model of multiple myeloma (MM) oncogenesis is based on the genetic instability of MM ce...
International audienceMultiple myeloma (MM) is a genetically complex hematological cancer that is ch...
Cancer cells and stromal cells cooperate by exchanging diffusible factors that sustain tumor growth,...
International audienceThe standard model of multiple myeloma (MM) relies on genetic instability in t...
Multiple myeloma (MM) is a hematologic malignancy of plasma cells proliferating in the bone marrow a...
Multiple myeloma is a malignant bone marrow plasma cell tumor which is responsible for approximately...
Multiple myeloma (MM) is a B cell malignancy resulting in osteolytic lesions and fractures. In the d...
Bone destruction is the hallmark of multiple myeloma (MM) due to the high capacity of malignant plas...
Multiple myeloma (MM) is a plasma cell malignancy characterized by the high capacity to induce bone ...